Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Universite D angers patents


Recent patent applications related to Universite D angers. Universite D angers is listed as an Agent/Assignee. Note: Universite D angers may have other listings under different names/spellings. We're not affiliated with Universite D angers, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "U" | Universite D angers-related inventors


Non-invasive assessing the presence or severity of liver fibrosis based on a new detailed classification

The present invention relates to for treating for an individual identified as suffering from a liver lesion, preferably liver fibrosis or cirrhosis. The present invention thus relates to a method invention for implementing an adapted patient care for an individual suffering from a liver lesion, preferably liver fibrosis or cirrhosis,... Universite D angers

Automatic measurement of lesions on medical images

A method for assessing the presence and/or the severity of a lesion in an organ or tissue of a subject through automated analysis of at least one image of the organ or tissue is provided. In particular, the organ or tissue is a liver organ or liver tissue. The method... Universite D angers

Compounds for the treatment of mitochondrial diseases

Disclosed is a compound of formula (Ia) for the use thereof in the treatment or prevention of diseases relating to the instability of mitochondrial DNA.... Universite D angers

Method for displaying easy-to-understand medical images

The present invention relates to a method for displaying an easy-to-understand medical image, comprising the steps of: a. obtaining a medical image, b. identifying at least one feature on the image of step (a), c. generating at least one mask highlighting the at least one feature, d. displaying at least... Universite D angers

Methods for determining whether a patient will achieve a response after radiation therapy

Disclosed are methods for determining whether a patient will achieve a response after radiation therapy, in particular a method for determining whether a patient suffering from a cancer will achieve a response after radiation therapy including the steps of i) determining the level of ceramide in a first blood sample... Universite D angers

Insecticide composition including a synergistic agent

Insecticide composition where the active ingredient includes a combination of at least one synthetic insecticidal molecule from the neonicotinoïd family, and at least one synergistic agent, which is chosen among the insect repellent agents and present in the composition at a molar ratio of the synergistic agent to the synthetic... Universite D angers

Use of a neurofilament peptide for targeting neural stem cells

The present invention shows that the isolated NFL-TBS40-63 peptide is highly specific for neural stem cells. It is therefore presented here for use in a method for detecting these cells in vitro or in vivo, for addressing chemical compounds or biological materials to said cells, or for treating neurodegenerative disorders... Universite D angers

Diagnosis of liver fibrosis or cirrhosis

This invention relates to method of diagnosing the presence and/or severity of a liver pathology and/or of monitoring the effectiveness of a curative treatment against a liver pathology in an individual, leading to a score, comprising the combination, of at least one marker from a blood test and of at... Universite D angers

Methods and pharmaceutical compositions for the cardioprotection

The present invention relates to methods and pharmaceutical compositions for cardioprotection of subjects who experienced a myocardial infarction. In particular, the present invention relates to a ligand of the sonic hedgehog signaling pathway for use in the cardioprotection of a subject who experienced a myocardial infarction.... Universite D angers

Prognostic tests for hepatic disorders

An in vitro prognostic method for assessing the risk of death or of liver-related event in a subject, includes: a) obtaining at least one, preferably 2, of the following variables from the subject: i. biomarkers measured in a sample from the subject; ii. clinical data; iii. binary markers; iv. blood... Universite D angers

Use of a neurofilament peptide for the treatment of glioma

The present invention provides a new drug to treat malignant glioma, which is the most prevalent type of primary tumor of the central nervous system (CNS). The present invention indeed shows that the isolated NFL-TBS40-63 peptide is highly specific for glioma cells, in which it triggers apoptosis. It is therefore... Universite D angers








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Universite D angers in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Universite D angers with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###